Work

A novel cream formulation containing nicotinamide 4%, arbutin 3%, bisabolol 1%, and retinaldehyde 0.05% for treatment of epidermal melasma.

Year: 2015

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: Elisete I Crocco, John V Veasey, Maria F Boin, Rute F Lellis, Renata O Alves

Language: English

Topic: Dermatologic Treatments and Research

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2410468464

FWCI: 1.398

Cites:

Cited by: 31

Related to: 10